Plethora Solutions Holdings Sells Lead Drug Rights, Cuts Debt by 90%

Reuters -- British urology specialist Plethora Solutions Holdings Plc said on Tuesday it had reduced its debt by over 90 percent as it received $8.4 million more for the global rights for its premature ejaculation drug from Sciele Pharma Inc.